Acumen Pharmaceuticals Inc
(ABOS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -100,606 | -92,257 | -88,355 | -26,997 | -7,325 |
| Depreciation Amortization | 159 | -5 | N/A | N/A | 0 |
| Accounts payable and accrued liabilities | 557 | -149 | 741 | 387 | 308 |
| Other Working Capital | 298 | -3,774 | 311 | 1,284 | 307 |
| Other Operating Activity | 81,631 | 81,863 | 80,669 | 22,956 | -740 |
| Operating Cash Flow | $-17,961 | $-14,322 | $-6,634 | $-2,370 | $-7,450 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -104,080 | -94,095 | N/A | N/A | N/A |
| PPE Investments | -40 | -14 | -6 | N/A | 0 |
| Investing Cash Flow | $-104,120 | $-94,109 | $-6 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 169,185 | 169,175 | 614 | N/A | N/A |
| Other Financing Activity | 31,281 | 31,281 | 31,061 | 0 | 44,675 |
| Financing Cash Flow | $200,466 | $200,456 | $31,675 | $N/A | $44,675 |
| Beginning Cash Position | 43,777 | 43,777 | 43,777 | 43,777 | 6,552 |
| End Cash Position | 122,162 | 135,802 | 68,812 | 41,407 | 43,777 |
| Net Cash Flow | $78,385 | $92,025 | $25,035 | $-2,370 | $37,225 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,961 | -14,322 | -6,634 | -2,370 | -7,450 |
| Capital Expenditure | -40 | -14 | -6 | N/A | N/A |
| Free Cash Flow | -18,001 | -14,336 | -6,640 | -2,370 | -7,450 |